Resolvin D series and protectin D1 mitigate acute kidney injury

Journal of Immunology

Volumn 177, Issue 9, 2006, Pages 5902-5911

  Duffield, Jeremy S ^a   Hong, Song ^a   Vaidya, Vishal S ^a   Lu, Yan ^a   Fredman, Gabrielle ^a   Serhan, Charles N ^a   Bonventre, Joseph V ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID; PROTECTIN D1; RESOLVIN D; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CONVALESCENCE; CREATININE BLOOD LEVEL; DISEASE MODEL; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; LEUKOCYTE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RENAL PROTECTION; REPERFUSION INJURY;

EID: 33745621719     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.9.5902     Document Type: Article

References (51)

1. Bonventre, J. V., and J. M. Weinberg. 2003. Recent advances in the pathophysiology of ischemic acute renal failure. J. Am. Soc. Nephrol. 14: 2199-2210.
2. Thadhani, R., M. Pascual, and J. V. Bonventre. 1996. Acute renal failure. N. Engl. J. Med. 334: 1448-1460.
3. Duffield, J. S., and J. V. Bonventre. 2004. Acute renal failure from Bench to Bedside. In Chronic Kidney Disease, Dialysis and Transplant 42, 2nd Ed. B. J. G. Pereira, M. H. Sayegh and P. Blake, eds. Elsevier Saunders, Philadelphia, pp 765-786.
4. Liano, F., and J. Pascual. 1996. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 50: 811-818.
5. Kelly, K. J., W. W. Williams, Jr., R. B. Colvin, S. M. Meehan, T. A. Springer, J. C. Gutierrez-Ramos, and J. V. Bonventre. 1996. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Invest. 97: 1056-1063.
6. Heyman, S. N., W. Lieberthal, P. Rogiers, and J. V. Bonventre. 2002. Animal models of acute tubular necrosis. Curr. Opin. Crit. Care 8: 526-534.
7. de Vries, B., J. Kohl, W. K. Leclercq, T. G. Wolfs, A. A. van Bijnen, P. Heeringa, and W. A. Buurman, 2003. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J. Immunol. 170: 3883-3889.
8. Bonventre, J. V., and A. Zuk. 2004. Ischemic acute renal failure: an inflammatory disease? Kidney Int. 66: 480-485.
9. Rabb, H., F. Daniels, M. O'Donnell, M. Haq, S. R. Saba, W. Keane, and W. W. Tang. 2000. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am. J. Physiol. 279: F525-F531.
10. Park, K. M., J. Y. Byun, C. Kramers, J. I. Kim, P. L. Huang, and J. V. Bonventre. 2003. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J. Biol. Chem. 278: 27256-27266.
11. Hirschberg, R. 2005. Wound healing in the kidney: complex interactions in renal interstitial fibrogenesis. J. Am. Soc. Nephrol. 16: 9-11.
12. Basile, D. P., D. Donohoe, K. Roethe, and J. L. Osborn. 2001. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am. J. Physiol. 281: F887-F899.
13. Mazzali, M., J. A. Jefferson, Z. Ni, N. D. Vaziri, and R. J. Johnson. 2003. Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int. 63: 2088-2093.
14. Kang, D. H., J. Kanellis, C. Hugo, L. Truong, S. Anderson, D. Kerjaschki, G. F. Schreiner, and R. J. Johnson. 2002. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 13: 806-816,
15. Eddy, A. A. 1994. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J. Am. Soc. Nephrol. 5: 1273-1287.
16. + T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108: 1283-1290.
17. Clish, C. B., J. A. O'Brien, K. Gronert, G. L. Stahl, N. A. Petasis, and C. N. Serhan. 1999. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. USA 96: 8247-8252.
18. Cailhier, J. F., M. Partolina, S. Vuthoori, S. Wu, K. Ko, S. Watson, J. Savill, J. Hughes, and R. A. Lang. 2005. Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation. J. Immunol. 174: 2336-2342.
19. Lovis, C., F. Mach, Y. R. Donati, J. V. Bonventre, and B. S. Polla. 1994. Heat shock proteins and the kidney. Renal Fail. 16: 179-192.
20. Maestri, M., D. C. Dafoe, G. A. Adams, A. Gaspari, F. Luzzana, F. Innocente, J. Rademacher, P. Dionigi, A. Barbieri, F. Zonta, et al. 1997. Insulin-like growth factor-I ameliorates delayed kidney graft function and the acute nephrotoxic effects of cyclosporine. Transplantation 64: 185-190.
21. de Vries, B., R. A. Matthijsen, A. A. van Bijnen, T. G. Wolfs, and W. A. Buurman. 2003. Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am. J. Pathol 163: 47-56.
22. Kourembanas, S., L. P. McQuillan, G. K. Leung, and D. V. Faller. 1993. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92: 99-104.
23. Serhan, C. N., S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, G. Mirick, and R. L. Moussignac. 2002. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196: 1025-1037.
24. Hong, S., K. Gronert, P. R. Devchand, R. L. Moussignac, and C. N. Serhan. 2003. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells: autacoids in anti-inflammation. J. Biol. Chem. 278: 14677-14687.
25. Serhan, C. N., K. Gotlinger, S. Hong, and M. Arita. 2004. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 73: 155-172.
26. Bannenberg, G. L., N. Chiang, A. Ariel, M. Arita, E. Tjonahen, K. H. Gotlinger, S. Hong, and C. N. Serhan. 2005. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174: 4345-4355.
27. Ariel, A., P. L. Li, W. Wang, W. X. Tang, G. Fredman, S. Hong, K. H. Gotlinger, and C. N. Serhan. 2005. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J. Biol. Chem. 280: 43079-43086.
28. Gronert, K., C. B. Clish, M. Romano, and C. N. Serhan. 1999. Transcellular regulation of eicosanoid biosynthesis. In Eicosanoid Protocols. E. A. Lianos, ed. Humana Press, Totowa, NJ, pp. 119-144.
29. Lu, Y., S. Hong, E. Tjonahen, and C. N. Serhan. 2005. Mediator-lipidomics: databases and search algorithms for PUFA-derived mediators. J. Lipid Res. 46: 790-802.
30. Serhan, C. N., C. B. Clish, J. Brannon, S. P. Colgan, N. Chiang, and K. Gronert. 2000. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192: 1197-1204.
31. Bazan, N. G. 2003. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J. Lipid Res. 44: 2221-2233.
32. Serhan, C. N. 2005. Novel omega-3-derived local mediators in anti-inflammation and resolution. Pharmacol. Ther. 105: 7-21.
33. Marcheselli, V. L., S. Hong, W. J. Lukiw, X. H. Tian, K. Gronert, A. Musto, M. Hardy, J. M. Gimenez, N. Chiang, C. N. Serhan, and N. G. Bazan. 2003. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278: 43807-43817.
34. Yang, R. 2005. Synthetic study of lipid mediators. In Department of Chemistry. University of Southern California, Los Angeles.
35. Duffield, J. S., S. J. Forbes, C. Constandinou, M. Clay, M. Partilona, S. Vuthoori, S. Wu, R. L. Lang, and J. P. Iredale. 2005. Depletion of macrophages reveals distinct and opposing functions during liver injury and repair. J. Clin. Invest. 115: 56-65.
36. Bradley, P. P., D. A. Priebat, R. D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78: 206-209.
37. Duffield, J. S., K. M. Park, L.-L. Hsiao, V. Kelley, D. T. Scadden, T. Ichimura, and J. V. Bonventre. 2005. Restoration of tubular epithelial cells in the postischemic kidney occurs independently of bone marrow-derived stem cells. J. Clin. Invest. 115: 1743-1755.
38. Castellani, S., and P. M. Adams. 1981. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur. J. Pharmacol. 73: 143-154.
39. Hung, C. C., T. Ichimura, J. L. Stevens, and J. V. Bonventre. 2003. Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation. J. Biol. Chem. 278: 29317-29326.
40. Duffield, J. S., L. P. Erwig, X. Wei, F. Y. Liew, A. J. Rees, and J. S. Savill. 2000. Activated macrophages direct apoptosis and suppress mitosis of mesangial cells. J. Immunol. 164: 2110-2119.
41. Serhan, C. N., K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S. P. Colgan, and N. A. Petasis. 2006. Anti-inflammatory actions of neuroprotectin D1/Protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176: 1848-1859.
42. Bannenberg, G., R. L. Moussignac, K. Gronert, P. R. Devchand, B. A. Schmidt, W. J. Guilford, J. G. Bauman, B. Subramanyam, H. D. Perez, J. F. Parkinson, and C. N. Serhan. 2004. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br. J. Pharmacol. 143: 43-52.
43. Doi, K., Y. Suzuki, A. Nakao, T. Fujita, and E. Noiri. 2004. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int. 65: 1714-1723.
44. McCord, J. M. 1985. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312: 159-163.
45. Daemen, M. A., M. W. van de Ven, E. Heineman, and W. A. Buurman. 1999. Involvement of endogenous interleukin-10 and tumor necrosis factor-α in renal ischemia-reperfusion injury. Transplantation 67: 792-800.
46. Kelly, K. J., W. W. Williams, Jr., R. B. Colvin, and J. V. Bonventre. 1994. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc. Natl. Acad. Sci. USA 91: 812-816.
47. Duffield, J. S., P. S. Tipping, M. Clay, J. F. Cailhier, T. Kipari, J. V. Bonventre, R. L. Lang, and J. H. Hughes. 2005. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am. J. Pathol. 167: 1207-1219.
48. Morgera, S., A. K. Kraft, G. Siebert, F. C. Luft, and H. H. Neumayer. 2002. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am. J. Kidney Dis. 40: 275-279.
49. Mukherjee, P. K., V. L. Marcheselli, C. N. Serhan, and N. G. Bazan. 2004. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA 101: 8491-8496.
50. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
51. Tapping, R. I., S. Akashi, K. Miyake, P. J. Godowski, and P. S. Tobias. 2000. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J. Immunol. 165: 5780-5787.